Status:
UNKNOWN
Epidemiology of Hepatitis B, C and Delta in Reunion Island
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Hepatitis B
Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
Viral hepatitis B, C and Δ represent a global public health problem for which France was very early mobilized. Despite this, in its foreword, the Dhumeaux report on "Management of people infected with...
Eligibility Criteria
Inclusion
- Major patient
- with confirmed HBsAg and / or anti HCV positive Ab
- residing in Reunion Island
- followed in one of the participating centers
Exclusion
- • Patient carrying isolated anti HBc antibodies
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03362866
Start Date
January 1 2019
End Date
April 1 2023
Last Update
September 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.